NFKB1 and familial pancreatic carcinoma: Our finding that UA enhanced the antitumor effect of gemcitabine in an animal model by inhibiting NF-κB and its downstream targets—leading to the inhibition of proliferation, angiogenesis, and invasion—suggests that UA has significant potential for the treatment of pancreatic cancer.